Eton Pharmaceuticals (ETON) Return on Equity [ROE] (2018 - 2026)
Eton Pharmaceuticals (ETON) reported Return on Equity [ROE] of 23.51% for Q2 2026, up 40.56 percentage points from -17.05% a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Eton Pharmaceuticals posted Return on Equity [ROE] of -18.19%, up 0.97 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +180.32 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -19.16% in FY2024 (-12.60 pp), -6.56% in FY2023 (+52.20 pp), -58.75% in FY2022 (-47.66 pp) and -11.09% in FY2021 (+187.42 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] in data going back to Q4 2018.
- Year over year, Return on Equity [ROE] gained in four of the last seven quarters, with an average year-over-year change of -1.36 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2021 (a gain of 487.19 percentage points); the low point was Q4 2022 (a drop of 62.63 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Eton Pharmaceuticals | 1.46 Bn | 1.34 Bn | 25.41 Mn | 23.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.51% |
| Dec 31, 2025 | -18.67% |
| Sep 30, 2025 | -28.38% |
| Jun 30, 2025 | -17.05% |
| Mar 31, 2025 | -18.76% |
| Dec 31, 2024 | -18.92% |
| Sep 30, 2024 | -37.23% |
| Jun 30, 2024 | -46.19% |
| Mar 31, 2024 | 5.90% |
| Dec 31, 2023 | -5.78% |
| Sep 30, 2023 | 13.28% |
| Jun 30, 2023 | -1.67% |
| Mar 31, 2023 | -52.23% |
| Dec 31, 2022 | -74.37% |
| Sep 30, 2022 | -72.83% |
| Jun 30, 2022 | -89.71% |
| Mar 31, 2022 | -79.97% |
| Dec 31, 2021 | -11.75% |
| Sep 30, 2021 | -58.69% |
| Jun 30, 2021 | -52.45% |
API Access
Eton Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();